The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

NCT02387359 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1054

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome Characterized by Constipation

Interventions

DRUG: Plecanatide
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.